| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |